Display options
Cite
Tucker TA, Jeffers A, Boren J, et al. Organizing empyema induced in mice by Streptococcus pneumoniae: effects of plasminogen activator inhibitor-1 deficiency. Clin Transl Med. 2016;5(1):17doi: 10.1186/s40169-016-0097-2.
Tucker, T. A., Jeffers, A., Boren, J., Quaid, B., Owens, S., Koenig, K. B., Tsukasaki, Y., Florova, G., Komissarov, A. A., Ikebe, M., & Idell, S. (2016). Organizing empyema induced in mice by Streptococcus pneumoniae: effects of plasminogen activator inhibitor-1 deficiency. Clinical and translational medicine, 5(1), 17. https://doi.org/10.1186/s40169-016-0097-2
Tucker, Torry A, et al. "Organizing empyema induced in mice by Streptococcus pneumoniae: effects of plasminogen activator inhibitor-1 deficiency." Clinical and translational medicine vol. 5,1 (2016): 17. doi: https://doi.org/10.1186/s40169-016-0097-2
Tucker TA, Jeffers A, Boren J, Quaid B, Owens S, Koenig KB, Tsukasaki Y, Florova G, Komissarov AA, Ikebe M, Idell S. Organizing empyema induced in mice by Streptococcus pneumoniae: effects of plasminogen activator inhibitor-1 deficiency. Clin Transl Med. 2016 Dec;5(1):17. doi: 10.1186/s40169-016-0097-2. Epub 2016 May 13. PMID: 27271877; PMCID: PMC4896893.
Copy Download .nbib Format: NLM
Share it on

Clin Transl Med. 2016 Dec;5(1):17. doi: 10.1186/s40169-016-0097-2. Epub 2016 May 13.

Organizing empyema induced in mice by Streptococcus pneumoniae: effects of plasminogen activator inhibitor-1 deficiency.

Clinical and translational medicine

Torry A Tucker, Ann Jeffers, Jake Boren, Brandon Quaid, Shuzi Owens, Kathleen B Koenig, Yoshikazu Tsukasaki, Galina Florova, Andrey A Komissarov, Mitsuo Ikebe, Steven Idell

Affiliations

  1. The Department of Cellular and Molecular Biology, The University of Texas Health Science Center at Tyler, 11937 US HWY 271, Biomedical Research Building, Lab C-5, Tyler, TX, 75708, USA. [email protected].
  2. The Department of Cellular and Molecular Biology, The University of Texas Health Science Center at Tyler, 11937 US HWY 271, Biomedical Research Building, Lab C-5, Tyler, TX, 75708, USA.

PMID: 27271877 PMCID: PMC4896893 DOI: 10.1186/s40169-016-0097-2

Abstract

BACKGROUND: Pleural infection affects about 65,000 patients annually in the US and UK. In this and other forms of pleural injury, mesothelial cells (PMCs) undergo a process called mesothelial (Meso) mesenchymal transition (MT), by which PMCs acquire a profibrogenic phenotype with increased expression of α-smooth muscle actin (α-SMA) and matrix proteins. MesoMT thereby contributes to pleural organization with fibrosis and lung restriction. Current murine empyema models are characterized by early mortality, limiting analysis of the pathogenesis of pleural organization and mechanisms that promote MesoMT after infection.

METHODS: A new murine empyema model was generated in C57BL/6 J mice by intrapleural delivery of Streptococcus pneumoniae (D39, 3 × 10(7)-5 × 10(9) cfu) to enable use of genetically manipulated animals. CT-scanning and pulmonary function tests were used to characterize the physiologic consequences of organizing empyema. Histology, immunohistochemistry, and immunofluorescence were used to assess pleural injury. ELISA, cytokine array and western analyses were used to assess pleural fluid mediators and markers of MesoMT in primary PMCs.

RESULTS: Induction of empyema was done through intranasal or intrapleural delivery of S. pneumoniae. Intranasal delivery impaired lung compliance (p < 0.05) and reduced lung volume (p < 0.05) by 7 days, but failed to reliably induce empyema and was characterized by unacceptable mortality. Intrapleural delivery of S. pneumoniae induced empyema by 24 h with lung restriction and development of pleural fibrosis which persisted for up to 14 days. Markers of MesoMT were increased in the visceral pleura of S. pneumoniae infected mice. KC, IL-17A, MIP-1β, MCP-1, PGE2 and plasmin activity were increased in pleural lavage of infected mice at 7 days. PAI-1(-/-) mice died within 4 days, had increased pleural inflammation and higher PGE2 levels than WT mice. PGE2 was induced in primary PMCs by uPA and plasmin and induced markers of MesoMT.

CONCLUSION: To our knowledge, this is the first murine model of subacute, organizing empyema. The model can be used to identify factors that, like PAI-1 deficiency, alter outcomes and dissect their contribution to pleural organization, rind formation and lung restriction.

Keywords: Plasminogen activator inhibitor-1; Pleural mesothelial cells; Pneumonia

References

  1. Am J Respir Cell Mol Biol. 2012 Feb;46(2):173-9 - PubMed
  2. Chest. 2009 Oct;136(4):1148-59 - PubMed
  3. Chest. 2000 Oct;118(4):1158-71 - PubMed
  4. Am J Respir Crit Care Med. 2006 Oct 1;174(7):817-23 - PubMed
  5. Am J Respir Cell Mol Biol. 2014 Feb;50(2):316-27 - PubMed
  6. J Immunol. 2007 Nov 1;179(9):6043-51 - PubMed
  7. J Clin Invest. 2010 Jun;120(6):1950-60 - PubMed
  8. Semin Thromb Hemost. 2013 Jun;39(4):373-81 - PubMed
  9. Respirology. 2011 May;16(4):598-603 - PubMed
  10. Br J Pharmacol. 2006 Nov;149(6):687-702 - PubMed
  11. Am J Respir Cell Mol Biol. 1992 Oct;7(4):414-26 - PubMed
  12. Am J Respir Cell Mol Biol. 2012 Feb;46(2):196-206 - PubMed
  13. N Engl J Med. 2005 Mar 3;352(9):865-74 - PubMed
  14. J Thorac Dis. 2012 Apr 1;4(2):186-93 - PubMed
  15. Am J Respir Cell Mol Biol. 2015 Jun;52(6):674-82 - PubMed
  16. J Thorac Cardiovasc Surg. 2007 Feb;133(2):346-51 - PubMed
  17. Am J Physiol Lung Cell Mol Physiol. 2015 Jun 15;308(12):L1265-73 - PubMed
  18. Eur Respir J. 2010 Jan;35(1):176-85 - PubMed
  19. J Biol Chem. 2011 Dec 9;286(49):41949-62 - PubMed
  20. Exp Lung Res. 2009 Oct;35(8):665-81 - PubMed
  21. Curr Opin Pulm Med. 2013 Jul;19(4):350-6 - PubMed
  22. Proc Am Thorac Soc. 2006;3(1):75-80 - PubMed
  23. Curr Opin Pulm Med. 2008 Jul;14(4):310-5 - PubMed
  24. Am J Respir Cell Mol Biol. 2012 Feb;46(2):180-7 - PubMed

Publication Types

Grant support